Burning Rock Biotech Limited (BNR)

Business: Burning Rock Biotech Limited primarily develops and provides cancer therapy selection tests in the People's Republic of China.

IPO Date: 12-Jun-2020

COO & Director: Dr. Shaokun Chuai

Founder, Chairman & CEO: Mr. Yusheng Han

Listing: NASDAQ: BNR

Country: China

Headquarters: Guangzhou,

Website: https://www.brbiotech.com

Market cap: $227.21 Mln

Revenue (TTM): CN¥536.76 Mln

Earnings (TTM): CN¥-925.07 Mln

Cash: CN¥1,329.27 Mln

Total Debt: CN¥77.48 Mln

Insider's Holding: 5.83%

Liquidity: Low

52 Week range: $1.74 - 30.50

Shares outstanding: 105,188,000

5 Years Aggregate:

• CFO: CN¥-1,061.95 Mln
• EBITDA: CN¥-1,550.15 Mln
• Net Profit: CN¥-1,681.86 Mln